Showing results (41-50 of 672) with videos related to
Sort By:
Pageof 68
Best Practice & Research. Clinical Haematology|June 20, 2006
Essential thrombocythaemiaClaire N Harrison, Anthony R GreenClinical Advances in Hematology & Oncology : H&O|May 10, 2018
Myelofibrosis: clinicopathologic features, prognosis, and managementJennifer M O'Sullivan, Claire N HarrisonBritish Journal of Haematology|March 14, 2020
Forging ahead or moving back: dilemmas and disappointments of novel agents for myeloproliferative neoplasmsDonal P McLornan, Claire N HarrisonPublic Health|August 9, 2005
Factors affecting the uptake of cardiac rehabilitation services in a rural localityW N Harrison, S A WardleFuture Oncology (London, England)|October 24, 2017
An updated review of the JAK1/2 inhibitor (ruxolitinib) in the Philadelphia-negative myeloproliferative neoplasmsNatalia Curto-Garcia, Claire N HarrisonHematology. American Society of Hematology. Education Program|February 20, 2015
Management of MPN beyond JAK2Claire N Harrison, Natalia Curto GarciaBlood|June 7, 2024
How I treat patients with low-risk polycythemia vera who require cytoreductionMary Frances McMullin, Claire N HarrisonImmunopharmacology|August 1, 1985
Effects of anti-inflammatory and anti-rheumatic drugs on the activities of purified and membrane-bound Na+/K+ adenosine triphosphataseM K Chan, J O MintaEar, Nose, & Throat Journal|April 1, 1990
The value of cytologic examination for nasopharyngeal carcinomaM K Chan, D P HuangPageof 68